POAI ‘s Helomics Division Announces Progress on Milestones for its AI-Driven Model of Ovarian Cancer

NEXT STORY
Lateral Flow Assays Market by Application, Product, Technique and End-user – Global Forecast to 2025
PREV STORY
Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl Therapeutics, a Wholly-owned Subsidiary of the Zydus Group, Sign Development and Asset Purchase Agreement for Cyprium Therapeutics’ Copper Histidinate Product Candidate for Treatment of Menkes Disease
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)

author_avatar
NASDAQ Market News

Immutep Announces Publication of AIPAC, TACTI-002 and TACTI-003 Abstracts for SITC 2021 Annual Meeting & AIPAC Global Webcast Details

author_avatar
NASDAQ Market News

Agenus Doses First Cancer Patient with iNKT Cell Therapy

author_avatar
NASDAQ Market News